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Summary.-Over the quinquennium 1964-68 the crude annual incidence of Kaposi's
sarcoma in Uganda per million of the population was 7-9 overall, 14 6 for males and
1.1 for females. Statistical analysis indicates that the disease is most prevalent in
highland areas to the west and among the indigenous Bantu tribes. There was no
correlation with the distribution of squamous cell carcinoma of the lower leg, and
Kaposi's sarcoma was not seen in an Indian or European during the period under
review.
NEARLY a century has passed since
Moricz Kaposi (1872) described the mul-
tiple pigmented haemorrhagic sarcoma of
skin now known as Kaposi's sarcoma.
Early observations in Europe and America
suggested that the disease was most pre-
valent in Russia, Poland and Northern
Italy (Dorffell, 1932). However, subse-
quent to a report of an African case from
the Cameroons (Jojot and Laigret, 1922)
it has become clear that the disease is
more prevalent in some parts of Africa
than elsewhere. The reports from various
African countries have been reviewed by
Maclean (1963). Ratio studies, ex-
pressing the number of cases of Kaposi's
sarcoma as a percentage of all cancers,
suggest that the relative frequency is
greatest in the N.E. Congo and in Rwanda
and Burundi, diminishing radially in all
directions (Oettle, 1962). The decrease
is, however, irregular. Thijs (1957) repor-
ted that the sarcoma formed 10-4%
of 221 cancers sent for histology to Stan-
leyville from Rwanda between 1939 and
1955, but Clemmesen, Maisin and Gigase
(1962) reported a ratio of only 0-9%O in
Rwanda and Burundi. A similar variable
distribution has been reported from
Tanzania (Burkitt and Slavin, 1968) and
Kenya where Rogoff (1968) noted that
the tribes with the highest incidence
lived in high, cool country with a moderate
rainfall. In Uganda, ratio studies (Cook
and Burkitt, 1970; Hutt and Burkitt,
1965) have suggested that the disease is
most prevalent in the west.
Race and sex
The crude incidence rate of the disease
in Caucasian American males is 0.081/
100,000, which is similar to the rate for
the U.S. negro (0-103/100,000) (Dorn
and Cutler, 1955) but in South Africa
Oettle (1962) observed that Kaposi's
sarcoma was 10 times more common
among the Bantu population than the
white. To what extent a difference in
environment or habit explains racial
differences is uncertain. The majority
of cases occur in men, and in East Africa
less than 10% of adult patients are
females (Slavin, Cameron and Singh,
1969), though below the age of 16 years
this figure may be as high as 24% (Slavin
et al., 1970). However, among South
* Present address, Department of Orthopaedic Surgery, P.O. Box 147, Liverpool.
t Address for reprints, Dr M. C. Pike, D.H1.S.S. Cancer Epidlemiology Unit.
J. F. TAYLOR, P. G. SMITH, DIANA BULL AND M. C. PIKE
African and Algerian whites, females
predominate in all age groups (Oettle,
1962; Mussini-Montpelier, 1953). The
female domestic environment differs from
one country to another and is unlikely to
be responsible for the predominant occur-
ence of the tumour in males in all con-
tinents. It is possible that the X chromo-
somes carry a recessive gene capable of
preventing initiation or maintenance of
the disease though this has been argued
against by Oettle (1962) because of the
low sex ratio in Durban Bantu and in
South African and Algerian whites.
In the present work we describe an
epidemiological analysis of the records
for Kaposi's sarcoma in the Kampala
Cancer Registry, Uganda.
Site of the investigation
Uganda lies at an altitude of about
4000 feet on the north shore of Lake
Victoria. In the central regions the
vegetation is mixed moist savanna and
shrub woodlands. Mount Elgon lies on
the Kenya border to the east, and further
north the dry savanna plains of Karamoja
adjoin the Sudan border. To the west
there is a gradual increase in altitude to
the mountains of Ankole and Kigezi,
and the Ruwenzoris on the Congo border
(Fig. 1). The climate is warm and
{ , l,,, . _ . _
* Above 7000 ft.
FIG. 1.-A relief map of Uganda. The areas of high altitude above 4000 feet should be compared
with the high incidence areas of Kaposi's sarcoma seen in Fig. 4.
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equable, lacking major seasonal changes.
The country is divided into administra-
tive districts and at the time of this study
there were 17 of these (Fig. 2). Each
district has a predominant tribe which
has been native to that area for the past
4 centuries. The indigenous people are
largely Bantu, but a southward migration
of northern tribes in about A.D. 1500
resulted in the establishment of the
Karamojong, Batesot and Sebei in
Uganda, and possibly also the Batutsi
in Rwanda (Murdock, 1959).
Background: patients and mnethods
Mulago Hospital, with its associated
Makerere University Medical School, is
situated at Kampala in Mengo district
on the northern shore of Lake Victoria.
The hospital provides specialist services
not available elsewhere, and the Depart-
ment of Pathology in the Medical School
provides a free diagnostic histological
service for all Ugandan hospitals. The
Kampala Cancer Registry in the Depart-
ment of Pathology maintains a record of
all patients in Uganda with microscopi-
cally proven cancers.
The present study is based upon an
analysis of the 339 patients of known sex
with Kaposi's sarcoma recorded by the
registry over the 5-year period 1964-68,
7 Teso
8 Toro
9 Mubende
10 West Mengo
11 East Mengo
12 Busoga
13 Bukedi
14 Bugisu (inc. Sebei)
15 Kigezi
16 Ankole
17 Masaka
Fir. 2. A map of Uganda showing the administrative (listricts.
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6
West Nile
Madi
Adcoli
Karamoja
Bunyoro
Lango
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all but 6 of the sarcomata being micro-
scopically proven. The details of each
patient's age, sex, tribe, place of residence
and date of presentation with the disease
have usually been obtained from the
form which accompanies the biopsy
specimen. When the home address was
omitted, that of the referring hospital
has been used. The disease is frequently
chronic and the sufferer may seek relief
at several hospitals. Though changes in
the spelling of his name or the location
of his home may result in over-registra-
tion, we have attempted to minimize
such errors by careful checking of each
record.
Information about the population
of Uganda was obtained from the 1959
and 1969 national censuses and we esti-
mated the population in 1966 (the middle
year in the quinquennium under review)
with the assistance of Mr K. Hill of the
Statistics Division of the Ministry of
Planning and Economic Development of
the Government of Uganda. Tribal infor-
mation was not collected in the 1969
census and the tribal incidence rates are
based on the 1959 census figures.
ANALYSIS AND RESULTS
During the 5-year period, the annual
registration of Kaposi's sarcoma remained
relatively constant, but there was a
steady increase in the annual number of
all cancers reported (Table I). Cook
TABLE I.-The New Registrations of
Patients with Cancer and of Patienis
with Kaposi's Sarcoma, and the Total
Number of Biopsies Examined, in the
Kampala Cancer Registry during the
Period 1964-68
Year
1964
1965
1966
1967
1968
Total
Patients with Patients with
cancer* Kaposi's sarcoma*
% of % of
5-year 5-year
No. total No. total
1305 17-8 . 61 17-9
1332 18-1 74 21 8
1399 19-0 . 72 21-2
1613 21-9 . 68 20 0
1702 23-2 . 65 19-1
7351 100-0 . 340 100-0
* 24 patients whose sex was not recorded are
included here; 1 of these patients had Kaposi's
sarcoma.
and Burkitt (1970) found that of the
patients with Kaposi's sarcoma reported
to them from Ugandan hospitals, 85%
had been sent for biopsy and it is probable
that, being superficial and interesting,
this tumour has always been well repor-
ted. Over the quinquennium the sar-
coma formed 8-0% of all male cancers
and 0-7% of all female cancers.
TABLE II.-The Average Annual Incidence of Kaposi's Sarcoma in Uganda
by Age and Sex* 1964-68
Male Female
A A, ,
Age
(years)
0- .
5-
15-
25-
35-
45-
55-
65-
75+
Total
45+
Estimated
1966
population
(OOOs)
823
1182
679
592
412
287
178
106
81
4340
651
Kaposi
patients
5 -0
6-0
25-8
63-1
73-7
63-9
52-5
16-7
9 -3
316 - 0
142 -4
Rate/ 106
year
1 -2
1-0
7-6
21 -3
35-8
44-5
59- 0
31 -5
23-0
14-6
43-7
Estimated
1966
population
(OOOs)
841
1134
718
614
388
266
156
87
58
4262
567
Kaposi
patients
2-1
1-1
1 -5
3-5
6-0
2-5
3-7
2-2
0-4
23-0
8-8
Rate/106/
year
0- 5
0-2
0-4
1-1
3-1
1-9
4-7
5- 1
1-4
1-1
3-1
* The sex of one patient was not recorded and this patient has been excluded from the study.
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Sex ratio
Table II shows that 316 male patients
with Kaposi's sarcoma were registered
compared with 23 females (6.8% females).
The male: female ratio was 13-7 overall,
3-4 below the age of 15 years (22.5%
females) and 15-4 in the older patients
(6.1% females). The sex of one patient
was not recorded and this patient is
excluded from all tables, except Table I.
Age incidence
The incidence of the tumour is shown
in Table II and illustrated in Fig. 3.
The age was not recorded for 24 of the
339 patients, and in order to estimate the
incidence rates we have divided those with
unknown age between age groups, in
proportion to the number of patients with
known age in each age group, within each
district. Thus, Table II shows fractional
patients in some age groups.
Though the greatest number ofpatients
seen was in the age group 35-44 years,
the male incidence rate can be seen to
increase steadily with age from late child-
hood to the age group 55-64 years. The
increase in female incidence is less marked.
In both sexes there is a slight decrease
in incidence in the 5-14 year age group.
INCIDENC
MILLION /
YEAR
This and the decrease seen in men above
the age of 65 years and in women above
the age of 75 years may be an artefact,
due to the small number of cases involved
and in the older age groups to the in-
accuracies of recorded age both in hospital
notes and in the census.
Geographic variation in incidence
The method of indirect standardiza-
tion has been used to investigate differ-
ences in incidence between the 17 dis-
tricts. Male and female age-specific inci-
dence rates were calculated for the country
as a whole, using 5-year age groupings
up to the age of 85 years. These national
rates were then multiplied by the popula-
tions in the appropriate age groups in each
district, to obtain the expected number of
patients with the disease, on the assump-
tion that the age- and sex-specific rates
were the same in each district. The ratio
of the observed to the expected number of
patients for each district was calculated,
to give a measure of the variation in
incidence between districts, called the
Standardized Morbidity Ratio (S.M.R.).
These are shown on the left side of Table
III and illustrated in Fig. 4.
0 Males
-*- Females
0 10 20 30 40
AGE (YEARS)
45+
FiG. 3.-The average annual incidence of Kaposi's sarcoma in Uganda for the period 1964-68.
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FiG. 4. The incidence of Kaposi's sarcoma in Uganda, standardized morbidity ratios, based upon the
estimated 1966 population. Mengo district lies on the north-west shore of Lake Victoria, and is
seen to have a relatively high incidence.
A difficulty in the interpretation of
such data is that any differences observed
might represent nothing more than varia-
tion in the reporting rates between
hospitals in different districts. There is
no entirely satisfactory way of compensa-
ting for such a possibility, but in order to
obtain some measure of this effect we
have considered, over the same time
period, Cancer Registry data for all
cancers, irrespective of type. Variation
in cancer incidence will not give a precise
measure of difference in reporting rates,
but it will give a crude measure of the
effect. S.M.R.s for all cancers are also
shown in Table III. The figures are in
line with what might be expected. The
ratio is low in the remote and nomadically
populated district of Karamoja and is
very high in Mengo. The S.M.R. exceeds
2 in West Mengo, the district including
the country's main hospital, Mulago,
in the capital city, Kampala. The raised
incidence of Kaposi's sarcoma in this
district might be explained by a high level
of reporting from doctors in Mengo, and
may be possibly influenced by a tendency
for persons with this and other cancers to
migrate to West Mengo specifically to be
treated there.
In an attempt to overcome possible
reporting differences between districts,
we have standardized the district rates
of Kaposi's sarcoma to the total cancer
cases reported in the 1964-68 period.
For the country as a whole, the percentage
of cancers which were Kaposi's sarcoma
were calculated in specific age-sex groups.
In each district the total cancer cases in
each age-sex group was multiplied by the
corresponding national rate of the sarcoma
as a percentage of all cancers. The expec-
ted cases thus derived were, in each dis-
trict, added across age-sex groupings to
give an expected total number of cases
of Kaposi's sarcoma for the district,
based upon the assumption that in each
age-sex group the sarcoma formed a
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FIG. 5. The incidence of Kaposi's sarcoma in Uganda. Standardized morbidity ratios based upon the
registered cases of all cancers. The incidence in Mengo district on the north-west shore of Lake
Victoria appears relatively low when calculated by this method. The areas of highest incidence
are those adjoining the western borders of Uganda.
constant proportion of all cancers in all
districts. The S.M.R.s are shown in
Table III and illustrated in Fig. 5.
The S.M.R.s based on the 1966 popula-
tion suggest that Kaposi's sarcoma was
most prevalent in the western districts of
Toro, West Nile, Kigezi, Ankole and also
in Madi and Mengo districts. However,
West and East Mengo ranked first and
second in the reporting of all cancers, and,
after standardizing to all cancers, Table
III and Fig. 5 show that the S.M.R. for
Kaposi's sarcoma in Mengo district is low
whereas the S.M.R.s for those districts
in the west and Madi district (4 cases
only) remain high. The lowest incidence
of the sarcoma is seen in Mubende and
Teso. The variations in incidence did not
correlate with the principal occupations,
crops or geology of the various districts.
During the period under review, 6
patients were registered from the dry,
sparsely inhabited district of Karamoja;
4 of these were first seen in 1965 and
2 in 1968. A similar uneven time distribu-
tion has been observed in several other
Ugandan districts. However, considered
as a whole, the variation is probably no
more than would be expected by chance.
Ethnic distribution
The crude incidence, uncorrected for
age, of Kaposi's sarcoma for males of
the predominant Ugandan tribes is shown
in Table IV. Included are tribes which
constitute at least 10% of the district
population except for a few tribes of
particular interest where the number falls
slightly below 10%; these are indicated
in the table. The rates shown are over-
estimates of the true rates as they are
based upon the 1959 census population,
the last occasion on which tribal data were
recorded. Patients whose tribe was not
known were divided in proportion to the
number of patients with known tribe
within each district. Also shown in the
table are male cases of Kaposi's sarcoma
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TABLE V.-The Crude Male Incidence Rates of Kaposi's Sarcoma in the Major
Ethnic Tribal Groupings in Uganda 1964-68
Ethnic origin
Bantu: Ganda .
Other tribes
Nilotic
Sudanic
Mixed (Rwanda--Rundi)
Others
1959
population
(000)
511 2
1309 0Q
854 - 2
172 3
301 2
89-0
in each district, by tribe, as a percentage
of all reported male cancers for the period
1964-68.
There is marked variation between
tribes resident in different districts and
this is related mostly to the varying
district incidence rates. It appears that,
in general, the indigenous tribes have a
higher incidence of the disease than the
immigrants from Rwanda and Burundi
(Table V). The Bantu tribes also tend to
have higher rates than the northern
Nilotic tribes but lower rates than the
Sudanic tribes, although differences may
be at least partially ascribed to varying
district reporting rates and also to geo-
graphic variation in incidence. Within
each district there are also considerable
differences between tribes although most
are not statistically significant. The
incidence in the Rwanda and Burundi
peoples (Rwandan-Rundis) who derive
from countries to the south and west
of Uganda is generally low. Combination
of the registrations for the Rwandan-
Rundis in Mengo, analysed by age
groups, shows a statistically significant
difference from the registered Ganda
patients, Table VI (X2 - 11X8, P < 0.01).
Also shown in Table VI are the total cases
of cancer reported amongst the Gandans
and Rwandan-Rundis over the same
time period. The standardized total can-
cer incidence rate for the Rwandan-
Rundis is about half that of the Gandans.
However, Kaposi's sarcoma as a percent-
age of all cancers by tribe is 2-2 times
(x2 4 5, P < 0.05) higher in the Gan-
dans, indicating that the difference in
Crude
Male rate/
Kaposi 100000/
cases 5 years
77 0
125-2
56-4
30-8
19-5
7-2
15-0
9-6
6-6
17-9
6-5
8-1
Kaposi
as % of
all cancers
6-8
9 9
6-6
14-0
5 9
4-5
the observed rates of Kaposi's sarcoma
is probably not an artefact. However,
in the adjacent district of Masaka,
Kaposi's sarcoma appears at approxi-
mately the same rate in Gandan and
Rwanda-Rundi tribes (Table IV).
Elsewhere in Uganda, Kaposi's sar-
coma appears to be most prevalent among
the dominant tribe, native to that district
(column A in Table IV). Thus, the rate
for the Kiga in Kigezi is higher than that
for the same tribe in Ankole, and the
rate for the Nkole in Ankole is higher
than in Masaka or in Mengo (where the
rate was 6.3/100,000/5 years and the
sarcoma formed 3.4% of all reported
cancers). It appears possible that either
the dominant tribe makes disproportionate
and greater use of the available medical
facilities or there is a recording bias
favouring the dominant tribe. However,
the data on all cancers in Mengo district
(Table VI) suggest that in Mengo at least
the differences cannot be completely
explained in this way.
An attempt was made to locate the
villages in which the patients with
Kaposi's sarcoma resided, on maps com-
piled by the Department of Lands and
Surveys, Government of Uganda. There
was no evidence that the disease was
limited by altitude, the heights of the
villages varied from 2050 to 7000 feet.
In order to obtain information on the
social status of people with the sarcoma,
25 patients with the disease living in
Mengo district were selected from con-
secutive new admissions to Mulago Hospi-
tal. Following interview in hospital,
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TABLE VII.-Standardized Morbidity Ratios in Males by District for Kaposi'sSarcoma
and Squamous Cell Carcinoma of the Lower Leg (Standardized to all Reported Male
Cancer Cases 1964-68)
Kaposi's sarcoma
A
Squamous cell carcinoma
lower leg
District (No.)
Toro (8)
West Nile (1)
Ankole (16)
Kigezi (15)
Madi (2)
Karamoja (4)
Busoga (12)
Lango (6)
E. Mengo (11)
Masaka (17)
Bukedi (13)
Bugisu (14)
Bunyoro (5)
W. Mengo (10)
Acholi (3)
Teso (7)
Mubende (9)
Total
No. of
cases
32
25
29
21
4
6
29
15
43
17
9
8
7
53
9
7
2
S.M.R.
2*11
1-77
1*64
1*54
1*50
1 27
1 04
0 97
0 93
0-89
0 87
0 74
0 73
0 70
0-62
0-51
0-45
Rank order
of S.M.R.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
No. of
cases
8
12
25
28
2
6
41
21
27
10
10
25
8
33
9
18
4
S.M.R.
0-61
0-98
1 66
2*29
0 94
1*27
1*53
1-50
0-63
0-58
1-07
2-57
0 94
0 47
0 75
1 -38
0 97
Rank order
of S.M.R.
15
9
3
2
12
7
4
5
14
16
8
1
11
17
13
6
10
316 - - 287
(Spearman Rank Correlation Coefficient 0*17, not statistically significant.)
their homes were visited and the findings
compared with 25 patients from the same
district admitted to Mulago Hospital
with septic or traumatic lesions, of similar
age, sex and tribe. Information was
gathered on socio-economic status, foot-
wear, house construction, insects present
in the house, proximity to neighbours, but
no marked differences were found between
the 2 groups.
The non-African population of Uganda
in 1959 was estimated at 46,328 males and
40,730 females. If the age-sex rates of
Kaposi's sarcoma shown in Table II
are applied to the non-African population
(83% of whom have Indian subcontinent
ethnic origins) an expected number of
3*9 patients is obtained for the period
1964-68. In fact all cases reported to
the Cancer Registry were in Africans.
Associated diseases
Three patients developed a second
neoplasm. One had lymphatic leukaemia,
one Hodgkin's disease and one carcinoma
of the penis.
DISCUSSION
The present work represents the first
detailed statistical analysis of the inci-
dence of Kaposi's sarcoma in Uganda.
The crude annual incidence rate per
million for the country as a whole was
7.9 for both sexes combined, 14-6 for
males and 1 1 for females. Previously,
Davies, Knowelden and Wilson (1965)
examined the Kampala Cancer Registry
records for 1954-64 and calculated a rate
of 25 per million in Kyadondo County,
which is part of Mengo district. How-
ever, we have presented evidence in
Table III to show that the high crude
rates in Mengo district may not represent
the incidence in a static population but
may be brought about by reporting differ-
ences, and also by sick people from up
country taking up residence around
Kampala to obtain treatment at Mulago
Hospital. Our crude national rate of
14-6 patients/million males/annum is,
however, higher than that of 10-0 given
by Oettle (1962) for the South African
Bantu.
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A steady increase with age in the
incidence rates has been observed in
South Africa by Oettle (1962) and is
partly confirmed here. The reduction in
the rate in the older age groups was not
observed by Oettle and is probably an
artefact due to the inaccuracies ofrecorded
age both in hospital notes and in the
census, and possibly also to a reluctance
of older persons to use the medical
facilities.
The male: female ratio of 13-7 is in
accord with the figure of 14-7 from the
Transvaal, 14*7 from America (Dorffell,
1932), 12*0 from Tanzania (Slavin et al.,
1969) and somewhat greater than the
7*2 reported for Kenya (Rogoff, 1968).
Of 14 children under the age of 15 years
in the present series, 3 were girls giving
a male: female ratio of 3'7. This is also
in agreement with the figure of 3-2
quoted by Slavin et al. (1970) for a series
of 51 patients in Tanzania and Uganda
aged less than 17 years. Slavin and his
colleagues reviewed Ugandan cases up to
1965 so that some of their cases will have
been included in our series. The reason
for the increase in the ratio after puberty
is unknown, but having been observed in
both American and Africa is unlikely to
be due to an environmental influence
affecting only one sex. The disease
occurs during pregnancy and is unaffected
by the oral administration of oestrogens
(Taylor et al., 1971). If the female is
protected by some sex-linked genetic
characteristic, it is unlikely to be med-
iated by hormones but by some other
means.
The analysis of incidence by districts
in Table III shows that the disease is
most prevalent in Toro, West Nile,
Ankole and Kigezi. This supports obser-
vations on the proportional rates of
Kaposi's sarcoma in selected Ugandan
hospitals (Cook and Burkitt, 1970).
These 4 western districts with a high
incidence adjoin Rwanda or the Congo
and are in a transitional zone between
the Ugandan savanna climate and the
Congo forests. Much of this zone is
highland, forest-savanna mosaics, with
a relatively high rainfall. These latter 3
factors also pertain in the relatively low
incidence area of Bugisu in the east.
However, whereas the highlands of the
west, with the exception of Kigezi, are
largely uncultivated, Bugisu has some of
the highest percentage of cultivated land
in the country (Uganda Government,
1967). Our findings lend some support
to the those of Rogoff (1968) who observed
that in Kenya the tumour was most pre-
valent in cool highland areas of moderate
rainfall. However, we also find a raised
incidence, although based on a small
number of patients, in the hot dry district
of Karamoja in the north-east. Williams
and Williams (1966) have suggested
that in West Nile District the simulium
fly might be involved in the transmission
of Kaposi's sarcoma as they found that
patients with the tumour tended to live
in areas where onchocerciasis was endemic.
Those species of simulium concerned with
the transmission of onchocerciasis breed
in free flowing streams which are fre-
quent in the hilly regions of Western
Uganda, but onchocerciasis is also ende-
mic in the East on the slopes of Mount
Elgon in Bugisu, an area relatively free
of the sarcoma. Further evidence against
the association is provided by McCrae,
Pike and Semakula (1968) who could
find no evidence of the appropriate species
of simulium fly in the Bukoba district
of Tanzania, an area known to have a
high incidence of the sarcoma. However,
a detailed investigation of the tumour
incidence in that part of Kenya adjoining
the Ugandan border would permit better
evaluation of the low incidence rates from
the western slopes of Mount Elgon.
The low incidence in Mubende is
difficult to assess. Patients from that
district may attend hospitals in Mengo
and the low incidence of all cancers in
Mubende supports this interpretation.
However, the incidence remains low after
standardization to all cancers and we can
thus offer no satisfactory explanation
ofthe observation.
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Kaposi's sarcoma usually presents
with lesions on the lower leg or foot,
suggesting that the disease may be
associated with trauma to the feet and
legs. Squamous cell carcinoma of the
leg is prone to occur in sites which sustain
repeated trauma or chronic ulceration
(Sutherland, 1958), and if trauma is an
important factor in Kaposi's sarcoma it
might be expected that the 2 diseases
would show similar geographical varia-
tion. We have examined data from the
Kampala Cancer Registry for the period
1964-68 for all microscopically proven
cases of squamous cell carcinoma of the
lower leg (S.C.C.L.) and have again
standardized the rates, by district, to all
reported cancer cases (Table VII). It
can be seen that the geographic distribu-
tion is quite different; S.C.C.L. predomin-
ates in Bugisu where Kaposi's sarcoma is
relatively rare and is uncommon in Toro,
the district with the highest rate of
Kaposi's sarcoma. This lack of correla-
tion between the 2 diseases leads us to
suspect that trauma is not an important
aetiological factor in the disease process.
The association of the sarcoma with
other neoplasms, including leukaemia
and Hodgkin's disease, confirms previous
reports (Moertel, 1966) without being
sufficiently strong to point to a common
aetiology. However, certain clinical and
pathological similarities exist between
Kaposi's sarcoma and Hodgkin's disease
(Taylor et al., 1971). It is of further
interest that Hodgkin's disease has recent-
ly been reported as occurring in a localized
epidemic (Vianna, Greenwald and Davies,
1971) and that of 6 patients with Kaposi's
sarcoma seen in the Karamoja district
in Uganda over a 5-year period, 4 were
first seen in 1965. These findings, and the
occasional reports of multiple cases of
Kaposi's sarcoma within one family
(Oettle, 1962), make it desirable that
further studies of the distribution of this
disease in space and time are under-
taken. These would be most profitable
in a stable rural community, rather
than in urban districts with a continu-
ously changing population such as found
around Kampala. However, as many
patients report to hospital some years
after the first onset of symptoms, such
studies will be difficult to conduct.
The extent to which differences in
incidence between districts are due to
ethnic rather than geographical factors
is not easy to assess as the 2 are confoun-
ded. In some districts more than one
tribe is represented but the differing
incidence between the Ganda and the
Rwandan-Rundis in Mengo is the only
one which is statistically significant.
The people from Rwanda and Burundi
who have settled in Mengo adopt some
of the local ways of life but are of lower
socio-economic status than the Ganda
(Bennett, 1966) and consequently differ
in many ways. In view of the finding
by Clemmesen et al. (1962) that Kaposi's
sarcoma was less prevalent in Rwanda
than in the Congo, further studies in these
areas are clearly desirable.
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